NULASTIN Inc

Enliven Therapeutics, Inc., based in Boulder, CO, is dedicated to advancing cancer treatment by not only extending patient lives but also enhancing the quality of life for those affected by the disease. The company specializes in developing small molecule kinase inhibitors that are designed to improve therapeutic efficacy, address treatment resistance, and ensure patient safety and convenience. With a team of experienced professionals, Enliven Therapeutics is committed to tackling complex challenges in oncology, such as brain metastases, through innovative approaches that prioritize precision and selectivity. Their mission is fueled by a passion for transforming cancer care and making a meaningful impact in the lives of patients. Generated from the website

Neurexis Therapeutics, based in Aurora, CO, is a pioneering biotech company dedicated to addressing the significant impact of stroke and cardiac arrest on human health. With a focus on neuroprotective innovation, Neurexis aims to reduce neuronal death and cognitive impairment caused by the loss of blood flow to the brain, offering a promising solution to an unmet medical need. By developing tatCN19o, an optimized peptide with proven efficacy and safety in animal models, Neurexis Therapeutics is at the forefront of advancing a potential FDA-approved neuroprotective treatment that can greatly improve the quality of life for patients and alleviate the burden on healthcare systems both domestically and internationally.Generated from the website